Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure

被引：27
|
作者：
Takeuchi, Tetsushiro [1 ]
Dohi, Kaoru [1 ]
Omori, Taku [1 ]
Moriwaki, Keishi [1 ]
Sato, Yuichi [1 ]
Nakamori, Shiro [1 ]
Fujimoto, Naoki [2 ]
Fujii, Eitaro [1 ]
Yamada, Norikazu [1 ]
Ito, Masaaki [1 ]
机构：
[1] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan
[2] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie 5148507, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 201卷
关键词：
Heart failure; Diabetes mellitus; Sodium-glucose cotransporter 2 inhibitor; Diuretics;
D O I：
10.1016/j.ijcard.2015.07.072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [1] Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure
    Choday, Silpa
    Ravi, Niriksha
    Parisapogu, Anusha
    Ojinna, Blessing T.
    Sherpa, Mingma L.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [2] Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure (vol 201, pg 1, 2015)
    Takeuchi, Tetsushiro
    Dohi, Kaoru
    Omori, Taku
    Moriwaki, Keishi
    Sato, Yuichi
    Nakamori, Shiro
    Fujimoto, Naoki
    Fujii, Eitaro
    Yamada, Norikazu
    Ito, Masaaki
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 206 : 173 - 173
  • [3] Acute natriuretic activity of sodium-glucose cotransporter 2 inhibitor in heart failure patients with type 2 diabetes mellitus
    Fukuoka, S.
    Dohi, K.
    Ishiyama, M.
    Takeuchi, T.
    Fujimoto, N.
    Ito, M.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 3067 - 3067
  • [4] Effect of sodium-glucose cotransporter-2 inhibitor administration on cardiac rehabilitation in patients with type 2 diabetes mellitus with heart failure
    Nakamura, S.
    Tanaka, E.
    Iso, Y.
    Fujihara, H.
    [J]. PHARMAZIE, 2023, 78 (6-7): : 100 - 105
  • [5] Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
    Lamos, Elizabeth M.
    Younk, Lisa M.
    Davis, Stephen N.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 763 - 775
  • [6] Usefulness of Sodium-Glucose Cotransporter 2 Inhibitors for Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus
    Arbel, Ronen
    Aboalhasan, Enis
    Hammerman, Ariel
    Azuri, Joseph
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 150 : 65 - 68
  • [7] Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
    Pradhan, Akshyaya
    Vohra, Shweta
    Vishwakarma, Pravesh
    Sethi, Rishi
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (06) : 1855 - 1862
  • [8] Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes
    Yanai, Hidekatsu
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [9] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Abdelhady, Hala A.
    Abakar, Adoum Oumar
    Gangavarapu, Ravindra Reddy
    Mahmud, Sayed A.
    Manandhar, Anura
    Sabir, Ghadeer
    Malasevskaia, Iana
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [10] Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
    Berg, David D.
    Wiviott, Stephen D.
    Scirica, Benjamin M.
    Gurmu, Yared
    Mosenzon, Ofri
    Murphy, Sabina A.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Johanson, Per
    Johansson, Peter A.
    Langkilde, Anna Maria
    Raz, Itamar
    Braunwald, Eugene
    Sabatine, Marc S.
    [J]. CIRCULATION, 2019, 140 (19) : 1569 - 1577
12345